Mouwasat Medical Services Company (TADAWUL:4002)
55.15
+0.55 (1.01%)
Nov 5, 2026, 3:19 PM AST
TADAWUL:4002 Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, TADAWUL:4002 stock has a consensus rating of "Buy" and an average price target of SAR 79.40. The average 1-year stock price forecast is 43.97% higher than the current stock price, while the lowest is SAR 57.00 (+3.35%) and the highest is SAR 106.00 (+92.20%).
Price Target: SAR 79.40 (+43.97%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for TADAWUL:4002 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 5 | 5 | 5 | 5 | 6 | 6 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 13 | 13 | 13 |
Financial Forecast
Revenue This Year
3.59B
from 3.22B
Increased by 11.46%
Revenue Next Year
3.93B
from 3.59B
Increased by 9.37%
EPS This Year
4.43
from 4.11
Increased by 7.79%
EPS Next Year
4.43
from 4.43
Decreased by -0.10%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.